ALMB-0168

· AlaMab Therapeutics (Shanghai) Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALMB-0168, covering 2021-05-14 to 2024-05-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy of ALMB-0168 in Solid Tumor Patients With Bone Metastatic Whose Prior Standard Treatment Have Failed [Phase 2]

See pricing